DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Rosenstock J, Rendell MS, Gross JL. et al.
Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1C) without causing weight gain or increased hypoglycaemia.
Diabetes Obes Metab 2009;
11: 1145-1152
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.